Breast cancer often exhibits Epidermal Growth Factor Receptor (EGFR) overexpression, and studies have reported that TNBC patients also exhibit EGFR overexpression with a prevalence rate that varies depending on the patient cohort11,12. This evidence concerns the gene EGFR and breast carcinoma.